EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Artificial intelligence and radiotherapy: Evolution or revolution?

Charlotte Robert, Philippe Meyer, Brigitte Séroussi, Thomas Leroy, Jean-Emmanuel Bibault

Cancer/Radiothérapie · 2024

DOI: 10.1016/j.canrad.2024.09.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer/Radiothérapie, 2024. Verfasst von Charlotte Robert und 4 weiteren Autor:innen. Beteiligte Einrichtung: Inserm, U1030 Molecular Radiotherapy and Therapeutic Innovation, Université Paris-Saclay, Gustave-Roussy, Villejuif, France; Department of Radiation …. Hauptthemen laut MEDLINE: Artificial Intelligence, Radiation Oncology. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The integration of artificial intelligence, particularly deep learning algorithms, into radiotherapy represents a transformative shift in the field, enhancing accuracy, efficiency, and personalized care. This paper explores the multifaceted impact of artificial intelligence on radiotherapy, the evolution of the roles of radiation oncologists and medical physicists, and the associated practical challenges. The adoption of artificial intelligence promises to revolutionize the profession by automating repetitive tasks, improving diagnostic precision, and enabling adaptive radiotherapy. However, it also introduces significant risks, such as automation bias, verification failures, and the potential erosion of clinical skills. Ethical considerations, such as maintaining patient autonomy and addressing biases in artificial intelligence systems, are critical to ensuring the responsible use of artificial intelligence. Continuous training and development of robust quality assurance programs are required to mitigate these risks and maximize the benefits of artificial intelligence in radiotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceRadiation OncologyHumansRadiotherapyNeoplasmsDeep LearningRadiation Oncologists

Stichwörter der Autor:innen

Artificial intelligenceIntelligence artificielleRadiation oncologyRadiothérapieRisksRisques

Autor:innen und Institutionen

  • Inserm, U1030 Molecular Radiotherapy and Therapeutic Innovation, Université Paris-Saclay, Gustave-Roussy, Villejuif, France; Department of Radiation Oncology, Gustave-Roussy, Villejuif, France.
  • Department of Radiotherapy, Institut de Cancérologie Strasbourg Europe (ICANS), Strasbourg, France; Icube, CNRS UMR 7357, team Images, Strasbourg, France.
  • Inserm, Laboratoire d'informatique médicale et d'ingénierie des connaissances en e-santé (Limics), Sorbonne université, université Sorbonne Paris Nord, 75006 Paris, France; Hôpital Tenon, AP-HP, Paris, France; Délégatio…
  • Department of Radiation Oncology, Centre de Cancérologie des Dentellières, Valenciennes, France. Electronic address: leroy@lesdentellieres.com.
  • Department of Radiation Oncology, Hôpital Europeen Georges-Pompidou, AP-HP, Université Paris-Cité, Paris, France; Institut du Cancer Paris Carpem, Université Paris-Cité, AP-HP, Paris, France.

Zitieren

APA

Robert, C., Meyer, P., Séroussi, B., Leroy, T., & Bibault, J. E. (2024). Artificial intelligence and radiotherapy: Evolution or revolution?. Cancer/Radiothérapie. https://doi.org/10.1016/j.canrad.2024.09.003

Vancouver

Robert C, Meyer P, Séroussi B, Leroy T, Bibault JE. Artificial intelligence and radiotherapy: Evolution or revolution?. Cancer/Radiothérapie. 2024. doi:10.1016/j.canrad.2024.09.003

BibTeX
@article{Robert2024,
  author = {Robert, Charlotte and Meyer, Philippe and Séroussi, Brigitte and Leroy, Thomas and Bibault, Jean-Emmanuel},
  title = {Artificial intelligence and radiotherapy: Evolution or revolution?},
  journal = {Cancer/Radiothérapie},
  year = {2024},
  doi = {10.1016/j.canrad.2024.09.003}
}
Kostenlos starten →